Skip to search formSkip to main contentSkip to account menu

BRL 15572

Known as: BRL-15572 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Abstract: The 5-HT1B/1D receptor antagonist, GR-127935, inhibits hypotensive responses produced by the 5-HT1A, 5-HT1B/1D and 5… 
2007
2007
1 In the present study, we investigated how alloxan‐induced diabetes affects the ability of 5‐hydroxytryptamine (5‐HT) to… 
2006
2006
Evidence suggests that 5-hydroxytriptamine-1B (5-HT1B) receptors play a role in modifying ethanol’s reinforcing effects and… 
2005
2005
In the present work we studied the actions of the intra-arterial administration of meta-chlorophenylpiperazine (m-CPP – a 5-HT2C… 
2002
1999
1999
The releases of [3H]5‐hydroxytryptamine ([3H]5‐HT) and of endogenous glutamic acid and their modulation through presynaptic h5…